查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
到 2030 年美国和欧洲基因编辑市场预测 - 按技术、产品和服务、应用程序和最终用户进行的国家/地区分析
市场调查报告书
商品编码
1347189

到 2030 年美国和欧洲基因编辑市场预测 - 按技术、产品和服务、应用程序和最终用户进行的国家/地区分析

US and Europe Gene Editing Market Forecast to 2030 - Country Analysis by Technology, Product and Service, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 146 Pages | 订单完成后即时交付

价格

美国和欧盟基因编辑市场预计将从2022年的39.5509亿美元增至2030年的150.5292亿美元；预计2022年至2030年復合年增长率为18.2%。

癌症和其他遗传性疾病患病率的上升以及基因编辑工具的持续技术进步等因素预计将推动美国和欧盟基因编辑市场的增长。此外，生物技术不断增长的创新和不断增加的投资预计也将在预测期内促进美国和欧盟基因编辑市场的增长。然而，基因编辑方法的高生产成本可能会阻碍美国和欧盟基因编辑市场的增长。

市场参与者开发新产品的战略倡议，以推动未来美国和欧盟基因编辑市场的发展

医疗保健 IT 领域的技术发展允许使用人工智能 (AI) 来製造 CRISPR 系统。医疗保健 IT 领域的开发人员致力于分析流程，以控制和监控产品开发的所有阶段。重点是开发从发现生物标誌物到临床试验和患者监测的技术。一些公司已经开始运用他们的专业知识，将人工智能用于数字製造。 2023 年 2 月，开发 CRISPR、合成生物学和人工智能 (AI) 技术的 Sherlock Biosciences 收购了 Sense Biodetection，这是一家位于英国牛津的快速分子检测平台开发商。此次收购增强了 Sherlock 将最先进的基于 CRISPR 的诊断技术方便地交付给全球消费者的能力。

2020年1月，ERS Genomics和New England Biolab合作开发并商业化CRISPR基因修饰工具和试剂。新英格兰生物实验室为基因组研究提供最齐全的重组酶和天然酶选择。该公司继续将其产品扩展到新的研究领域，包括基因组编辑。作为 CRISPR/Cas9 试剂和工具的提供商，NEB 从 ERS ​​Genomics 获得的许可扩大了该公司使用和销售这些技术的权利。

因此，此类倡议预计将在未来几年促进基因组编辑并促进美国和欧盟基因编辑市场的增长。

美国和欧盟基因编辑市场根据技术、产品和服务、应用和最终用户进行细分。根据技术分为 CRISPR、TALEN、反义、锌指核酸酶 (ZFN) 等。 2022年，CRISPR细分市场占据美国和欧盟基因编辑市场的最大份额。此外，预计同一细分市场在未来几年也将以最快的速度增长。根据产品和服务分为试剂和耗材、仪器和其他。 2022年，试剂和耗材领域在美国和欧盟基因编辑市场中占据最大份额。此外，预计同一细分市场在未来几年也将以最快的速度增长。根据应用分为细胞系工程、基因工程、诊断应用、药物发现等。 2022年，细胞系工程领域占据最大的市场份额。此外，预计同一细分市场在未来几年也将以最快的速度增长。根据最终用户分为製药和生物技术公司、学术和研究机构、合同研究组织 (CRO) 等。 2022年，製药和生物技术公司细分市场在美国和欧盟基因编辑市场中占据最大份额。然而，学术和研究机构部门预计在未来几年将以最快的速度增长。

世界卫生组织 (WHO)、农业基因组学研究中心 (CRAG)、疾病控制与预防中心 (CDC)、环境、食品和农村事务部 (DEFRA)、粮食及农业组织 (FAO)、美国美国和欧盟基因编辑市场报告在准备时参考了一些主要和次要来源，其中包括美国食品和药物管理局(FDA)、意大利农业遗传学会(SIGA)。

目录

第 1 章：简介

  • 研究范围
  • Insight Partners 研究报告指南
  • 市场区隔
    • 美国和欧洲基因编辑市场-按技术分类
    • 美国和欧洲基因编辑市场 - 按产品和服务分类
    • 美国和欧洲基因编辑市场- 按应用
    • 美国和欧洲基因编辑市场 - 按最终用户划分
    • 基因编辑市场-按地域划分

第 2 章：执行摘要

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：美国和欧洲基因编辑市场 - 市场格局

  • 概述
  • PEST分析
    • 美国 - PEST 分析
    • 欧洲 - PEST 分析
  • 专家意见

第 5 章：基因编辑市场 - 主要市场动态

  • 市场驱动因素
    • 癌症和其他遗传性疾病患病率上升
    • 基因编辑工具的持续技术进步
  • 市场限制
    • 基因编辑方法的生产成本高
  • 市场机会
    • 美国和欧洲不断发展的生物技术产业
  • 未来的趋势
    • 市场参与者开发新产品的战略倡议
  • 影响分析

第 6 章：基因编辑市场 - 美国和欧洲分析

  • 美国和欧洲基因编辑市场收入预测与分析
  • 关键参与者的市场定位

第 7 章：美国和欧洲基因编辑市场分析 - 按技术

  • 概述
  • 基因编辑技术
  • 泰伦
  • 反义
  • 锌指核酸酶 (ZFN)
  • 其他的

第 8 章：美国和欧洲基因编辑市场分析 - 按产品和服务

  • 概述
  • 试剂及耗材
  • 仪器
  • 其他的

第 9 章：美国和欧洲基因编辑市场分析 -按应用

  • 概述
  • 细胞系工程
  • 基因工程
  • 诊断应用
  • 药物发现
  • 其他的

第 10 章：美国和欧洲基因编辑市场分析 - 按最终用户

  • 概述
  • 製药与生物技术公司
  • 学术及研究机构
  • 合同研究组织 (CRO)
  • 其他的

第 11 章：美国和欧洲基因编辑市场分析

  • 美国基因编辑市场收入预测与分析
    • 概述
  • 欧洲基因编辑市场收入预测与分析
    • 概述

第 12 章：行业格局

  • 概述
  • 美国和欧洲基因编辑市场的增长策略
  • 有机增长策略
    • 概述
  • 无机增长策略
    • 概述

第 13 章：公司简介

  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • Lonza Group AG
  • Horizon Discovery Group plc.
  • Integrated DNA Technologies, Inc.
  • GenScript Biotech Corporation
  • New England Biolabs
  • Eurofins Scientific SE
  • CRISPR Therapeutics
  • Editas Medicine Inc
  • ElevateBio LLC

第 14 章：附录

  • 专业术语
Product Code: TIPRE00029986

The US & EU gene editing market is projected to reach US$ 15,052.92 million by 2030 from US$ 3,955.09 million in 2022; it is expected to grow at a CAGR of 18.2% from 2022 to 2030.

The factors such as rise in the prevalence of cancer and other genetic disorders and continuous technological advancements in gene editing tools are expected to drive the US & EU gene editing market growth. Moreover, growing innovations and rising investments in biotechnology is also expected to foster the US & EU gene editing market growth during the forecast period. However, the high cost of production of gene editing methods may hinder the US & EU gene editing market growth.

Strategic Initiatives by Market Players to Develop New Products to Boost the US & EU Gene Editing Market in Future

Technological developments in healthcare IT allow the use of artificial intelligence (AI) for manufacturing CRISPR Systems. Developers working in the healthcare IT domain are engaged in analyzing the processes to control and monitor all the stages of product development. The focus is to develop technologies from discovering biomarkers to clinical trials and patient monitoring. A few companies have initiated implementing their expertise to use AI for digital manufacturing. In February 2023, Sherlock Biosciences, which develops CRISPR, synthetic biology, and artificial intelligence (AI) technologies, acquired Sense Biodetection, an Oxford, UK-based developer of a rapid molecular testing platform. This acquisition accelerates Sherlock's ability to put the most advanced CRISPR-based diagnostics conveniently in the hands of global consumers.

In January 2020, ERS Genomics and New England Biolab collaborated to develop and commercialize CRISPR gene modification tools and reagents. New England Biolab offers the largest selection of recombinant and native enzymes for genomic research. The company continues expanding its product offerings into new research areas, including genome editing. As a provider of CRISPR/Cas9 reagents and tools, NEB's license from ERS Genomics expands the company's rights to use and sell these technologies.

Thus, such initiatives are expected to foster genome editing and enhance the US & EU gene editing market growth in the coming years.

The US & EU gene editing market is segmented on the basis of technology, product and services, application, and end user. Based on the technology is segmented into CRISPR, TALEN, antisense, Zinc Finger Nucleases (ZFNs), and others. In 2022, the CRISPR segment held the largest share of the US & EU gene editing market. Moreover, the same segment is also expected to grow at the fastest rate during the coming years. Based on the products and services is segmented into reagents and consumables, instruments, and others. In 2022, the reagents and consumables segment held the largest share of the US & EU gene editing market. Moreover, the same segment is also expected to grow at the fastest rate during the coming years. Based on the application is segmented into cell line engineering, genetic engineering, diagnostic application, drug discovery, and others. In 2022, the cell line engineering segment held the largest share of the market. Moreover, the same segment is also expected to grow at the fastest rate during the coming years. Based on the end user is segmented into pharmaceutical & biotechnology companies, academic and research institutes, contract research organization (CROs), others. In 2022, the pharmaceutical & biotechnology companies segment held the largest share of the US & EU gene editing market. However, the academic and research institutes segment is expected to grow at the fastest rate during the coming years.

The World Health Organization (WHO), Centre For Research in Agricultural Genomics (CRAG), Centers for Disease Control and Prevention (CDC), Department For Environment, Food, And Rural Affairs (DEFRA), Food And Agricultural Organization (FAO), US Food and Drug Administration (FDA), Italian Society of Agricultural Genetics (SIGA) are among some of the primary and secondary sources referred to while preparing the report on the US & EU gene editing market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the US and Europe Gene editing market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the US and Europe Gene editing market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 US and Europe Gene Editing Market- By Technology
    • 1.3.2 US and Europe Gene Editing Market- By Products and Services
    • 1.3.3 US and Europe Gene Editing Market- By Application
    • 1.3.4 US and Europe Gene Editing Market- By End User
    • 1.3.5 Gene Editing Market- By Geography

2. Executive Summary

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. US and Europe Gene Editing Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 US - PEST Analysis
    • 4.2.2 Europe - PEST Analysis
  • 4.3 Expert Opinions

5. Gene Editing Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rise in Prevalence of Cancer and Other Genetic Disorders
    • 5.1.2 Continuous Technological Advancements in Gene Editing Tools
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Production of Gene Editing Methods
  • 5.3 Market Opportunities
    • 5.3.1 Growing Biotechnology Industry in US and Europe
  • 5.4 Future Trends
    • 5.4.1 Strategic Initiatives by Market Players to Develop New Products
  • 5.5 Impact Analysis

6. Gene Editing Market - US and Europe Analysis

  • 6.1 US and Europe Gene Editing Market Revenue Forecast and Analysis
  • 6.2 Market Positioning of Key Players

7. US and Europe Gene Editing Market Analysis - By Technology

  • 7.1 Overview
    • 7.1.1 US and Europe Gene Editing Market, By Technology 2022 & 2030 (%)
  • 7.2 CRISPR
    • 7.2.1 Overview
    • 7.2.2 US and Europe CRISPR Market Revenue and Forecasts to 2030 (US$ Million)
  • 7.3 TALEN
    • 7.3.1 Overview
    • 7.3.2 US and Europe TALEN Market Revenue and Forecasts to 2030 (US$ Million)
  • 7.4 Antisense
    • 7.4.1 Overview
    • 7.4.2 US and Europe Antisense Market Revenue and Forecasts to 2030 (US$ Million)
  • 7.5 Zinc Finger Nucleases (ZFNs)
    • 7.5.1 Overview
    • 7.5.2 US and Europe Zinc Finger Nucleases (ZFNs)Market Revenue and Forecasts to 2030 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)

8. US and Europe Gene Editing Market Analysis - By Products and Services

  • 8.1 Overview
    • 8.1.1 US and Europe Gene Editing Market, By Products and Services 2022 & 2030 (%)
  • 8.2 Reagents and Consumables
    • 8.2.1 Overview
    • 8.2.2 US and Europe Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
  • 8.3 Instruments
    • 8.3.1 Overview
    • 8.3.2 US and Europe Instruments Market Revenue and Forecasts to 2030 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)

9. US and Europe Gene Editing Market Analysis - By Application

  • 9.1 Overview
    • 9.1.1 US and Europe Gene Editing Market, By Application 2022 & 2030 (%)
  • 9.2 Cell Line Engineering
    • 9.2.1 Overview
    • 9.2.2 US and Europe Cell Line Engineering Market Revenue and Forecasts to 2030 (US$ Million)
  • 9.3 Genetic Engineering
    • 9.3.1 Overview
    • 9.3.2 US and Europe Genetic Engineering Market Revenue and Forecasts to 2030 (US$ Million)
  • 9.4 Diagnostic Application
    • 9.4.1 Overview
    • 9.4.2 US and Europe Diagnostic Application Market Revenue and Forecasts to 2030 (US$ Million)
  • 9.5 Drug Discovery
    • 9.5.1 Overview
    • 9.5.2 US and Europe Drug Discovery Market Revenue and Forecasts to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)

10. US and Europe Gene Editing Market Analysis - By End User

  • 10.1 Overview
    • 10.1.1 US and Europe Gene Editing Market, By End User 2022 & 2030 (%)
  • 10.2 Pharmaceutical & Biotechnology Companies
    • 10.2.1 Overview
    • 10.2.2 US and Europe Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
  • 10.3 Academic and Research Institutes
    • 10.3.1 Overview
    • 10.3.2 US and Europe Academic and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
  • 10.4 Contract Research Organization (CROs)
    • 10.4.1 Overview
    • 10.4.2 US and Europe Contract Research Organization (CROs) Market Revenue and Forecasts to 2030 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)

11. US and Europe Gene Editing Market Analysis

  • 11.1 US Gene Editing Market Revenue Forecast and Analysis
    • 11.1.1 Overview
    • 11.1.2 US: Gene Editing Market - Revenue and Forecasts to 2030 (USD Million)
    • 11.1.3 US: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
    • 11.1.4 US: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
    • 11.1.5 US: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
    • 11.1.6 US: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
  • 11.2 Europe Gene Editing Market Revenue Forecast and Analysis
    • 11.2.1 Overview
    • 11.2.2 Europe: Gene Editing Market - Revenue and Forecasts to 2030 (USD Million)
    • 11.2.3 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
    • 11.2.4 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
    • 11.2.5 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
    • 11.2.6 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
    • 11.2.7 Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Country (%)
    • 11.2.8 Germany: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.8.1 Germany: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.8.2 Germany: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
      • 11.2.8.3 Germany: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
      • 11.2.8.4 Germany: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
      • 11.2.8.5 Germany: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
    • 11.2.9 UK: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.9.1 UK: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.9.2 UK: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
      • 11.2.9.3 UK: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
      • 11.2.9.4 UK: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
      • 11.2.9.5 UK: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
    • 11.2.10 France: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.10.1 France: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.10.2 France: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
      • 11.2.10.3 France: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
      • 11.2.10.4 France: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
      • 11.2.10.5 France: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
    • 11.2.11 Italy: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.11.1 Italy: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.11.2 Italy: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
      • 11.2.11.3 Italy: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
      • 11.2.11.4 Italy: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
      • 11.2.11.5 Italy: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
    • 11.2.12 Spain: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.12.1 Spain: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.12.2 Spain: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
      • 11.2.12.3 Spain: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
      • 11.2.12.4 Spain: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
      • 11.2.12.5 Spain: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)
    • 11.2.13 Rest of Europe: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.13.1 Rest of Europe: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
      • 11.2.13.2 Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Technology (USD Million)
      • 11.2.13.3 Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Products and Services (USD Million)
      • 11.2.13.4 Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By Application (USD Million)
      • 11.2.13.5 Rest of Europe: Gene Editing Market- Revenue and Forecasts to 2030, By End User (USD Million)

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in US and Europe Gene Editing Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Thermo Fisher Scientific Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Merck KGaA
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Lonza Group AG
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Horizon Discovery Group plc.
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Integrated DNA Technologies, Inc.
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 GenScript Biotech Corporation
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 New England Biolabs
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Eurofins Scientific SE
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 CRISPR Therapeutics
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Editas Medicine Inc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 ElevateBio LLC
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments

14. Appendix

  • 14.1 Glossary of Terms

List Of Tables

  • Table 1. US: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
  • Table 2. US: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
  • Table 3. US: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
  • Table 4. US: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
  • Table 5. Europe: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
  • Table 6. Europe: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
  • Table 7. Europe: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
  • Table 8. Europe: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
  • Table 9. Germany: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
  • Table 10. Germany: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
  • Table 11. Germany: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
  • Table 12. Germany: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
  • Table 13. UK: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
  • Table 14. UK: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
  • Table 15. UK: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
  • Table 16. UK: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
  • Table 17. France: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
  • Table 18. France: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
  • Table 19. France: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
  • Table 20. France: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
  • Table 21. Italy: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
  • Table 22. Italy: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
  • Table 23. Italy: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
  • Table 24. Italy: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
  • Table 25. Spain: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
  • Table 26. Spain: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
  • Table 27. Spain: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
  • Table 28. Spain: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
  • Table 29. Rest of Europe: Gene Editing Market, By Technology - Revenue and Forecast to 2030 (USD Million)
  • Table 30. Rest of Europe: Gene Editing Market, By Products and Services - Revenue and Forecast to 2030 (USD Million)
  • Table 31. Rest of Europe: Gene Editing Market, By Application- Revenue and Forecast to 2030 (USD Million)
  • Table 32. Rest of Europe: Gene Editing Market, By End User- Revenue and Forecast to 2030 (USD Million)
  • Table 33. Recent Organic Growth Strategies in US and Europe Gene Editing Market
  • Table 34. Recent Inorganic Growth Strategies in the US and Europe Gene Editing Market
  • Table 35. Glossary of Terms, Gene Editing Market

List Of Figures

  • Figure 1. Gene Editing Market Segmentation
  • Figure 2. Gene Editing Market Segmentation, by Region
  • Figure 3. US and Europe Gene Editing Market Overview
  • Figure 4. CRISPR Segment Held Largest Share of Gene Editing Market
  • Figure 5. UK to Show Significant Growth During Forecast Period
  • Figure 6. US and Europe Gene Editing Market - Leading Country Markets (US$ Million)
  • Figure 7. US and Europe Gene Editing Market, Industry Landscape
  • Figure 8. US PEST Analysis
  • Figure 9. Europe PEST Analysis
  • Figure 10. Gene Editing Market - Key Industry Dynamics
  • Figure 11. Gene Editing Market Impact Analysis of Drivers and Restraints
  • Figure 12. US and Europe Gene Editing Market - Revenue Forecast and Analysis - 2020-2030
  • Figure 13. Market Positioning of Key Players in US and Europe Gene Editing Market
  • Figure 14. US and Europe Gene Editing Market, By Technology 2022 & 2030 (%)
  • Figure 15. US and Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 16. US and Europe TALEN Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 17. US and Europe Antisense Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 18. US and Europe Zinc Finger Nucleases (ZFNs) Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 19. US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 20. US and Europe Gene Editing Market, By Products and Services 2022 & 2030 (%)
  • Figure 21. US and Europe Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 22. US and Europe Instruments Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 23. US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 24. US and Europe Gene Editing Market, By Application 2022 & 2030 (%)
  • Figure 25. US and Europe Cell Line Engineering Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 26. US and Europe Genetic Engineering Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 27. US and Europe Diagnostic Application Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 28. US and Europe Drug Discovery Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 29. US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 30. US and Europe Gene Editing Market, By End User 2022 & 2030 (%)
  • Figure 31. US and Europe Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 32. US and Europe Academic and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 33. US and Europe Contract Research Organization (CROs) Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 34. US and Europe Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 35. US Gene Editing Market- Revenue Forecast and Analysis - 2020- 2030
  • Figure 36. Europe Gene Editing Market- Revenue Forecast and Analysis - 2020- 2030
  • Figure 37. Europe: Gene Editing Market -Revenue and Forecasts to 2030, By Country (%)
  • Figure 38. Germany: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
  • Figure 39. UK: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
  • Figure 40. France: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
  • Figure 41. Italy: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
  • Figure 42. Spain: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
  • Figure 43. Rest of Europe: Gene Editing Market - Revenue and Forecast to 2030 (USD Million)
  • Figure 44. Growth Strategies in US and Europe Gene Editing Market